← Eichor
Condition: Chronic Total Coronary Occlusions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Total Coronary Occlusions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Chronic Total Occlusion Registry
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT02352818
Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention
NA · 1 location(s) · National Institute of Cardiology, Warsaw, Poland · NCT06275386
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Phase N/A · 2 location(s) · IRCCS Ospedale San Raffaele · NCT07013344
The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)
Phase N/A · 1 location(s) · Segeberger Kliniken GmbH · NCT06957613
PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlus
NA · 1 location(s) · Erasmus Medical Center · NCT05230446
TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)
Phase N/A · 3 location(s) · National Taiwan University Hospital · NCT06917378
The DECISION-CTO Extended 10 Y Follow-up
Phase N/A · 19 location(s) · Seung-Jung Park · NCT06908499
Revascularization Versus Optimal Medical Therapy of Chronic Total Coronary Occlusions on Left Ventricular Ischemia Reduc
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT03756870
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06137521
Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions
Phase N/A · 21 location(s) · National Institute of Cardiology, Warsaw, Poland · NCT07330622
Drug-Coated Coronary Balloons in Different Clinical Scenarios
Phase N/A · 5 location(s) · Kutahya Health Sciences University · NCT06915597
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion
Phase N/A · 1 location(s) · Lin Zhao · NCT07020858
VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions
NA · 2 location(s) · VasoStar, LLC · NCT06193954
Calcification on CTCA of a CTO and PCI Outcomes
Phase N/A · 1 location(s) · Sandwell & West Birmingham Hospitals NHS Trust · NCT06414551
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Les
NA · 18 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT07463664
Use of Physiology to Evaluate Procedural Result After PCI CTO
NA · 2 location(s) · Isala · NCT04780971
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06542653
FAPI Imaging Assessment of Chronic Total Occlusion
Phase N/A · 2 location(s) · Lin Zhao · NCT06655922
Japanese CTO PCI Expert Registry
Phase N/A · 1 location(s) · Kurashiki Central Hospital · NCT01889459
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Ch
Phase N/A · 32 location(s) · Seung-Whan Lee, M.D., Ph.D. · NCT03667196
To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conv
NA · 1 location(s) · CCRF Inc., Beijing, China · NCT04944615
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary
Phase N/A · 1 location(s) · Cathreine BV · NCT07114393
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NA · 27 location(s) · Aarhus University Hospital Skejby · NCT03563417
Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial
NA · 1 location(s) · Biruni University · NCT07369765
Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI
NA · 3 location(s) · National Institute of Cardiology, Warsaw, Poland · NCT06878729
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.